Impact of baseline covariates on the immunogenicity of the 9-valent HPV vaccine – A combined analysis of five phase III clinical trials

• Main Authors: Lone K. Petersen, Jaime Restrepo, Edson D. Moreira, Ole Erik Iversen, Punnee Pitisuttithum, Pierre Van Damme, Elmar A. Joura, Sven Erik Olsson, Daron Ferris, Stan Block, Anna R. Giuliano, Xavier Bosch, Sophie Pils, Jack Cuzick, Suzanne M. Garland, Warner Huh, Susanne K. Kjaer, Oliver M. Bautista, Donna Hyatt, Roger Maansson, Erin Moeller, Hong Qi, Christine Roberts, Alain Luxembourg
• Other Authors: Ârhus Universitetshospital
• Format: Article
• Published: 2018
• Subjects: Immunology and Microbiology
• Online Access: https://repository.li.mahidol.ac.th/handle/123456789/42786
• Institution: Mahidol University

© 2017 The Authors Background The immunogenicity profile of the 9-valent HPV (9vHPV) vaccine was evaluated across five phase III clinical studies conducted in girls and boys 9–15 years of age and young women 16–26 years of age. The effect of baseline characteristics of subjects on vaccine-induced HP...